International Biotechnology Valuation
| IBT Stock | 692.00 20.00 2.81% |
At this time, the firm appears to be overvalued. International Biotechnology retains a regular Real Value of USD578.92 per share. The prevalent price of the firm is USD692.0. Our model calculates the value of International Biotechnology from evaluating the firm fundamentals such as Return On Equity of 0.14, current valuation of 274.82 M, and Return On Asset of 0.0806 as well as inspecting its technical indicators and probability of bankruptcy.
Price Book 0.8725 | Enterprise Value 274.8 M | Price Sales 6.5828 | Forward PE 714.2857 | Trailing PE 6.7843 |
Overvalued
Today
Please note that International Biotechnology's price fluctuation is very steady at this time. Calculation of the real value of International Biotechnology is based on 3 months time horizon. Increasing International Biotechnology's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the International stock is determined by what a typical buyer is willing to pay for full or partial control of International Biotechnology Trust. Since International Biotechnology is currently traded on the exchange, buyers and sellers on that exchange determine the market value of International Stock. However, International Biotechnology's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 692.0 | Real 578.92 | Hype 692.0 | Naive 704.28 |
The real value of International Stock, also known as its intrinsic value, is the underlying worth of International Biotechnology Company, which is reflected in its stock price. It is based on International Biotechnology's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of International Biotechnology's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of International Biotechnology Trust helps investors to forecast how International stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of International Biotechnology more accurately as focusing exclusively on International Biotechnology's fundamentals will not take into account other important factors: International Biotechnology Cash |
|
International Biotechnology Total Value Analysis
International Biotechnology Trust is currently forecasted to have takeover price of 274.82 M with market capitalization of 246.48 M, debt of 22.83 M, and cash on hands of . Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the International Biotechnology fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
274.82 M | 246.48 M | 22.83 M |
International Biotechnology Investor Information
About 26.0% of the company shares are owned by institutional investors. The company has price-to-book (P/B) ratio of 0.87. Some equities with similar Price to Book (P/B) outperform the market in the long run. International Biotechnology last dividend was issued on the 19th of December 2024. Based on the key measurements obtained from International Biotechnology's financial statements, International Biotechnology Trust is performing exceptionally good at this time. It has a great probability to report excellent financial results in March.International Biotechnology Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. International Biotechnology has an asset utilization ratio of 13.03 percent. This indicates that the Company is making USD0.13 for each dollar of assets. An increasing asset utilization means that International Biotechnology Trust is more efficient with each dollar of assets it utilizes for everyday operations.International Biotechnology Ownership Allocation
International Biotechnology Trust has a total of 35.62 Million outstanding shares. Roughly 72.22 (percent) of International Biotechnology outstanding shares are held by general public with 1.41 % owned by insiders and only 26.37 pct. by outside corporations. Please note that no matter how many assets the company holds, if the real value of the firm is less than the current market value, you may not be able to make money on it.International Biotechnology Profitability Analysis
The company reported the revenue of 40.14 M. Net Income was 38.88 M with profit before overhead, payroll, taxes, and interest of 42.88 M.International Biotechnology Past Distributions to stockholders
Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates International Biotechnology's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in International Biotechnology and how it compares across the competition.
About International Biotechnology Valuation
The stock valuation mechanism determines International Biotechnology's current worth on a weekly basis. Our valuation model uses a comparative analysis of International Biotechnology. We calculate exposure to International Biotechnology's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of International Biotechnology's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 26.7 M | 19.8 M |
Complementary Tools for International Stock analysis
When running International Biotechnology's price analysis, check to measure International Biotechnology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy International Biotechnology is operating at the current time. Most of International Biotechnology's value examination focuses on studying past and present price action to predict the probability of International Biotechnology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move International Biotechnology's price. Additionally, you may evaluate how the addition of International Biotechnology to your portfolios can decrease your overall portfolio volatility.
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Stocks Directory Find actively traded stocks across global markets | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance |